NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22
| Errataetall: |
ErratumFor: J Clin Invest. 2016 May 2;126(5):1783-800. - PMID 27043286 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:133 |
|---|---|
| Enthalten in: |
The Journal of clinical investigation - 133(2023), 4 vom: 15. Feb. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Spalinger, Marianne R [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 16.02.2023 Date Revised 01.04.2023 published: Electronic ErratumFor: J Clin Invest. 2016 May 2;126(5):1783-800. - PMID 27043286 Citation Status MEDLINE |
|---|
| doi: |
10.1172/JCI169304 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM352938854 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM352938854 | ||
| 003 | DE-627 | ||
| 005 | 20231226054848.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1172/JCI169304 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1176.xml |
| 035 | |a (DE-627)NLM352938854 | ||
| 035 | |a (NLM)36787260 | ||
| 035 | |a (PII)e169304 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Spalinger, Marianne R |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22 |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.02.2023 | ||
| 500 | |a Date Revised 01.04.2023 | ||
| 500 | |a published: Electronic | ||
| 500 | |a ErratumFor: J Clin Invest. 2016 May 2;126(5):1783-800. - PMID 27043286 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Published Erratum | |
| 650 | 7 | |a NLR Family, Pyrin Domain-Containing 3 Protein |2 NLM | |
| 650 | 7 | |a Protein Tyrosine Phosphatases |2 NLM | |
| 650 | 7 | |a EC 3.1.3.48 |2 NLM | |
| 650 | 7 | |a Tyrosine |2 NLM | |
| 650 | 7 | |a 42HK56048U |2 NLM | |
| 650 | 7 | |a Protein Tyrosine Phosphatase, Non-Receptor Type 22 |2 NLM | |
| 650 | 7 | |a EC 3.1.3.48 |2 NLM | |
| 650 | 7 | |a PTPN22 protein, human |2 NLM | |
| 650 | 7 | |a EC 3.1.3.48 |2 NLM | |
| 700 | 1 | |a Kasper, Stephanie |e verfasserin |4 aut | |
| 700 | 1 | |a Gottier, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Lang, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Atrott, Kirstin |e verfasserin |4 aut | |
| 700 | 1 | |a Vavricka, Stephan R |e verfasserin |4 aut | |
| 700 | 1 | |a Scharl, Sylvie |e verfasserin |4 aut | |
| 700 | 1 | |a Gutte, Petrus M |e verfasserin |4 aut | |
| 700 | 1 | |a Grütter, Markus G |e verfasserin |4 aut | |
| 700 | 1 | |a Beer, Hans-Dietmar |e verfasserin |4 aut | |
| 700 | 1 | |a Contassot, Emmanuel |e verfasserin |4 aut | |
| 700 | 1 | |a Chan, Andrew C |e verfasserin |4 aut | |
| 700 | 1 | |a Dai, Xuezhi |e verfasserin |4 aut | |
| 700 | 1 | |a Rawlings, David J |e verfasserin |4 aut | |
| 700 | 1 | |a Mair, Florian |e verfasserin |4 aut | |
| 700 | 1 | |a Becher, Burkhard |e verfasserin |4 aut | |
| 700 | 1 | |a Falk, Werner |e verfasserin |4 aut | |
| 700 | 1 | |a Fried, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Rogler, Gerhard |e verfasserin |4 aut | |
| 700 | 1 | |a Scharl, Michael |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of clinical investigation |d 1924 |g 133(2023), 4 vom: 15. Feb. |w (DE-627)NLM000005487 |x 1558-8238 |7 nnns |
| 773 | 1 | 8 | |g volume:133 |g year:2023 |g number:4 |g day:15 |g month:02 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1172/JCI169304 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 133 |j 2023 |e 4 |b 15 |c 02 | ||